Procalcitonin is elevated in the cerebrospinal fluid of patients with dementia and acute neuroinflammation

Journal of Neuroimmunology

Volumn 189, Issue 1-2, 2007, Pages 169-174

  Ernst, Andrea ^b,e   Morgenthaler, Nils G ^a,e   Buerger, Katharina ^c   Dodel, Richard ^d   Noelker, Carmen ^d   Sommer, Norbert ^d   Schwarz, Markus ^c   Koehrle, Josef ^e   Bergmann, Andreas ^a,b   Hampel, Harald ^c,f  

^a BRAHMS AG   (Germany)

^b SPHINGOTEC GMBH   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

^d PHILIPPS UNIVERSITY MARBURG   (Germany)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^f TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Alzheimer's disease; Cerebrospinal fluid; Dementia; Diagnosis; Inflammation; Procalcitonin

Indexed keywords

BIOLOGICAL MARKER; PROCALCITONIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; DEMENTIA; ENCEPHALITIS; FEMALE; FRONTOTEMPORAL DEMENTIA; HUMAN; IMMUNOASSAY; INFLAMMATION; LEWY BODY; MALE; MENINGITIS; MULTIINFARCT DEMENTIA; NEUROINFLAMMATION; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CALCITONIN; CASE-CONTROL STUDIES; DEMENTIA; ENCEPHALITIS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROGENIC INFLAMMATION; PROTEIN PRECURSORS; ROC CURVE;

EID: 34548566095     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2007.07.009     Document Type: Article

References (42)

1. Akiyama H., Barger S., Barnum S., Bradt B., Bauer J., Cole G.M., Cooper N.R., Eikelenboom P., Emmerling M., Fiebich B.L., Finch C.E., Frautschy S., Griffin W.S., Hampel H., Hull M., Landreth G., Lue L., Mrak R., Mackenzie I.R., McGeer P.L., O'Banion M.K., Pachter J., Pasinetti G., Plata-Salaman C., Rogers J., Rydel R., Shen Y., Streit W., Strohmeyer R., Tooyoma I., Van Muiswinkel F.L., Veerhuis R., Walker D., Webster S., Wegrzyniak B., Wenk G., and Wyss-Coray T. Inflammation and Alzheimer's disease. Neurobiol. Aging 21 (2000) 383-421
2. Assicot M., Gendrel D., Carsin H., Raymond J., Guilbaud J., and Bohuon C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 341 (1993) 515-518
3. Becker K.L., Nylen E.S., White J.C., Muller B., and Snider Jr. R.H. Clinical review 167: procalcitonin and the calcitonin gene family of peptides in inflammation, infection, and sepsis: a journey from calcitonin back to its precursors. J. Clin. Endocrinol. Metab. 89 (2004) 1512-1525
4. Berres M., Monsch A.U., Bernasconi F., Thalmann B., and Stahelin H.B. Normal ranges of neuropsychological tests for the diagnosis of Alzheimer's disease. Stud. Health Technol. Inform. 77 (2000) 195-199
5. Blennow K. Cerebrospinal fluid protein biomarkers for Alzheimer's disease. NeuroRX: J. Am. Soc. Exp. Neurother. 1 (2004) 213-225
6. Bonifati D.M., and Kishore U. Role of complement in neurodegeneration and neuroinflammation. Mol. Immunol. 44 (2007) 999-1010
7. Bosco D.A., Fowler D.M., Zhang Q., Nieva J., Powers E.T., Wentworth Jr. P., Lerner R.A., and Kelly J.W. Elevated levels of oxidized cholesterol metabolites in Lewy body disease brains accelerate alpha-synuclein fibrilization. Nat. Chem. Biol. 2 (2006) 249-253
8. Christ-Crain M., Jaccard-Stolz D., Bingisser R., Gencay M.M., Huber P.R., Tamm M., and Muller B. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet 363 (2004) 600-607
9. Christ-Crain M., Stolz D., Bingisser R., Muller C., Miedinger D., Huber P.R., Zimmerli W., Harbarth S., Tamm M., and Muller B. Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. Am. J. Respir. Crit. Care Med. 174 (2006) 84-93
10. Dandona P., Nix D., Wilson M.F., Aljada A., Love J., Assicot M., and Bohuon C. Procalcitonin increase after endotoxin injection in normal subjects. J. Clin. Endocrinol. Metab. 79 (1994) 1605-1608
11. Engelhart M.J., Geerlings M.I., Meijer J., Kiliaan A., Ruitenberg A., van Swieten J.C., Stijnen T., Hofman A., Witteman J.C., and Breteler M.M. Inflammatory proteins in plasma and the risk of dementia: the Rotterdam study. Arch. Neurol. 61 (2004) 668-672
12. Gendrel D., Assicot M., Raymond J., Moulin F., Francoual C., Badoual J., and Bohuon C. Procalcitonin as a marker for the early diagnosis of neonatal infection. J. Pediatr. 128 (1996) 570-573
13. Gendrel D., Raymond J., Assicot M., Moulin F., Iniguez J.L., Lebon P., and Bohuon C. Measurement of procalcitonin levels in children with bacterial or viral meningitis. Clin. Infect. Dis. 24 (1997) 1240-1242
14. Groups T.L.a.M. Clinical and neuropathological criteria for frontotemporal dementia. J. Neurol. Neurosurg. Psychiatry 57 (1994) 416-418
15. Gupta A., and Pansari K. Inflammation and Alzheimer's disease. Int. J. Clin. Pract. 57 (2003) 36-39
16. Gupta A., Watkins A., Thomas P., Majer R., Habubi N., Morris G., and Pansari K. Coagulation and inflammatory markers in Alzheimer's and vascular dementia. Int. J. Clin. Pract. 59 (2005) 52-57
17. Han Y.Y., Carcillo J.A., Ruppel R.A., Adelson P.D., Wisniewski S.R., Bell M.J., Janesko K.L., Marion D.W., and Kochanek P.M. Cerebrospinal fluid procalcitonin and severe traumatic brain injury in children. Pediatr. Crit. Care Med. 3 (2002) 39-44
18. Jereb M., Muzlovic I., Hojker S., and Strle F. Predictive value of serum and cerebrospinal fluid procalcitonin levels for the diagnosis of bacterial meningitis. Infection 29 (2001) 209-212
19. Jia J.P., Meng R., Sun Y.X., Sun W.J., Ji X.M., and Jia L.F. Cerebrospinal fluid tau, Abeta1-42 and inflammatory cytokines in patients with Alzheimer's disease and vascular dementia. Neurosci. Lett. 383 (2005) 12-16
20. Katsuse O., Iseki E., and Kosaka K. Immunohistochemical study of the expression of cytokines and nitric oxide synthases in brains of patients with dementia with Lewy bodies. Neuropathol. 23 (2003) 9-15
21. Kepa L., Oczko-Grzesik B., and Bledowski D. Procalcitonin (PCT) concentration in cerebrospinal fluid and plasma of patients with purulent and lymphocytic meningoencephalitis-own observations. Przegl. Epidemiol. 59 (2005) 703-709
22. Lotric-Furlan S., Maraspin-Carman V., Cimperman J., Ogrinc K., Stopar T., and Strle F. Procalcitonin levels in patients with Lyme borreliosis. Wien. Klin. Wochenschr. 114 (2002) 530-532
23. Mackenzie I.R. Activated microglia in dementia with Lewy bodies. Neurology 55 (2000) 132-134
24. Mackenzie I.R. Cortical inflammation in dementia with Lewy bodies. Arch. Neurol. 58 (2001) 519-520
25. McKeith I.G., Galasko D., Kosaka K., Perry E.K., Dickson D.W., Hansen L.A., Salmon D.P., Lowe J., Mirra S.S., Byrne E.J., Lennox G., Quinn N.P., Edwardson J.A., Ince P.G., Bergeron C., Burns A., Miller B.L., Lovestone S., Collerton D., Jansen E.N., Ballard C., de Vos R.A., Wilcock G.K., Jellinger K.A., and Perry R.H. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 47 (1996) 1113-1124
26. McKhann G., Drachman D., Folstein M., Katzman R., Price D., and Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34 (1984) 939-944
27. Mimoz O., Benoist J.F., Edouard A.R., Assicot M., Bohuon C., and Samii K. Procalcitonin and C-reactive protein during the early posttraumatic systemic inflammatory response syndrome. Intensive Care Med. 24 (1998) 185-188
28. Minghetti L. Role of inflammation in neurodegenerative diseases. Curr. Opin. Neurol. 18 (2005) 315-321
29. Morgenthaler N.G., Struck J., Fischer-Schulz C., and Bergmann A. Sensitive immunoluminometric assay for the detection of procalcitonin. Clin. Chem. 48 (2002) 788-790
30. Morgenthaler N.G., Struck J., Chancerelle Y., Weglohner W., Agay D., Bohuon C., Suarez-Domenech V., Bergmann A., and Muller B. Production of procalcitonin (PCT) in non-thyroidal tissue after LPS injection. Horm. Metab. Res. 35 (2003) 290-295
31. Morgenthaler N.G., Struck J., Christ-Crain M., Bergmann A., and Muller B. Pro-atrial natriuretic peptide is a prognostic marker in sepsis, similar to the APACHE II score: an observational study. Crit. Care 9 (2005) R37-R45
32. Muller B., White J.C., Nylen E.S., Snider R.H., Becker K.L., and Habener J.F. Ubiquitous expression of the calcitonin-i gene in multiple tissues in response to sepsis. J. Clin. Endocrinol. Metab. 86 (2001) 396-404
33. Nylen E.S., O'Neill W., Jordan M.H., Snider R.H., Moore C.F., Lewis M., Silva O.L., and Becker K.L. Serum procalcitonin as an index of inhalation injury in burns. Horm. Metab. Res. 24 (1992) 439-443
34. Rau B., Steinbach G., Gansauge F., Mayer J.M., Grunert A., and Beger H.G. The potential role of procalcitonin and interleukin 8 in the prediction of infected necrosis in acute pancreatitis. Gut 41 (1997) 832-840
35. Rentzos M., Zoga M., Paraskevas G.P., Kapaki E., Rombos A., Nikolaou C., Tsoutsou A., and Vassilopoulos D. IL-15 is elevated in cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia. J. Geriatr. Psychiatry Neurol. 19 (2006) 114-117
36. Roman G.C., Tatemichi T.K., Erkinjuntti T., Cummings J.L., Masdeu J.C., Garcia J.H., Amaducci L., Orgogozo J.M., Brun A., Hofman A., et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 43 (1993) 250-260
37. Shimetani N., Shimetani K., and Mori M. Levels of three inflammation markers, C-reactive protein, serum amyloid A protein and procalcitonin, in the serum and cerebrospinal fluid of patients with meningitis. Scand. J. Clin. Lab. Invest. 61 (2001) 567-574
38. Sjogren M., Folkesson S., Blennow K., and Tarkowski E. Increased intrathecal inflammatory activity in frontotemporal dementia: pathophysiological implications. J. Neurol. Neurosurg. Psychiatry 75 (2004) 1107-1111
39. Snider Jr. R.H., Nylen E.S., and Becker K.L. Procalcitonin and its component peptides in systemic inflammation: immunochemical characterization. J. Investig. Med. 45 (1997) 552-560
40. Wada-Isoe K., Wakutani Y., Urakami K., and Nakashima K. Elevated interleukin-6 levels in cerebrospinal fluid of vascular dementia patients. Acta Neurol. Scand. 110 (2004) 124-127
41. Whang K.T., Steinwald P.M., White J.C., Nylen E.S., Snider R.H., Simon G.L., Goldberg R.L., and Becker K.L. Serum calcitonin precursors in sepsis and systemic inflammation. J. Clin. Endocrinol. Metab. 83 (1998) 3296-3301
42. Zweig M.H., and Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin. Chem. 39 (1993) 561-577